Literature DB >> 2414656

In vitro synthesis of a 28 kilodalton antigen present on the surface of the schistosomulum of Schistosoma mansoni.

J M Balloul, R J Pierce, J M Grzych, A Capron.   

Abstract

Adult Schistosoma mansoni proteins were fractionated on polyacrylamide slab gels, recovered by electrophoretic elution and used for immunization of Fischer rats. Three antisera recognizing, respectively, 28, 78 and 85 kDa antigens were obtained. The 28 kDa antigen was found among the in vitro translation products from adult worm RNA, and among the 125I-labelled surface antigens of S. mansoni schistosomula. The isoelectric point of the 28 kDa antigen was 6.3-6.5. The 28 kDa antiserum mediated a cytotoxic activity against schistosomula when used in an in vitro assay in the presence of a purified eosinophil cell population.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2414656     DOI： 10.1016/0166-6851(85)90131-8

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN： 0166-6851            Impact factor:   1.759


  13 in total

Review 1.  IgE and immune defense mechanism.

Authors:  J P Dessaint; A Capron
Journal:  Clin Rev Allergy       Date:  1989

2.  Relationship of impairment of schistosome 28-kilodalton glutathione S-transferase (GST) activity to expression of immunity to Schistosoma mattheei in calves vaccinated with recombinant Schistosoma bovis 28-kilodalton GST.

Authors:  J M Grzych; J De Bont; J Liu; J L Neyrinck; J Fontaine; J Vercruysse; A Capron
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

Review 3.  Progress in molecular parasitology.

Authors:  P Köhler
Journal:  Experientia       Date:  1986-04-15

4.  Comparison of the in vitro translation capacity of Taenia crassiceps metacestode mRNA prepared by the phenol and cesium chloride method.

Authors:  R Kleine-Herzbruch; E Geyer
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

5.  Helper T cells induced by a purified 28-kilodalton antigen of Schistosoma mansoni protect rats against infection.

Authors:  C Auriault; J M Balloul; R J Pierce; M Damonneville; P Sondermeijer; A Capron
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

6.  Of monkeys and men: immunomic profiling of sera from humans and non-human primates resistant to schistosomiasis reveals novel potential vaccine candidates.

Authors:  Mark S Pearson; Luke Becker; Patrick Driguez; Neil D Young; Soraya Gaze; Tiago Mendes; Xiao-Hong Li; Denise L Doolan; Nicholas Midzi; Takafira Mduluza; Donald P McManus; R Alan Wilson; Jeffrey M Bethony; Norman Nausch; Francisca Mutapi; Philip L Felgner; Alex Loukas
Journal:  Front Immunol       Date:  2015-05-05       Impact factor: 7.561

7.  Sm29, but not Sm22.6 retains its ability to induce a protective immune response in mice previously exposed to a Schistosoma mansoni infection.

Authors:  Clarice Carvalho Alves; Neusa Araujo; Viviane Cristina Fernandes dos Santos; Flávia Bubula Couto; Natan R G Assis; Suellen B Morais; Sérgio Costa Oliveira; Cristina Toscano Fonseca
Journal:  PLoS Negl Trop Dis       Date:  2015-02-27

8.  The glutathione transferase activity and tissue distribution of a cloned Mr28K protective antigen of Schistosoma mansoni.

Authors:  J B Taylor; A Vidal; G Torpier; D J Meyer; C Roitsch; J M Balloul; C Southan; P Sondermeyer; S Pemble; J P Lecocq
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

9.  Schistosoma mansoni shares a protective carbohydrate epitope with keyhole limpet hemocyanin.

Authors:  J M Grzych; C Dissous; M Capron; S Torres; P H Lambert; A Capron
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

10.  Cytokine responses to the anti-schistosome vaccine candidate antigen glutathione-S-transferase vary with host age and are boosted by praziquantel treatment.

Authors:  Claire D Bourke; Norman Nausch; Nadine Rujeni; Laura J Appleby; François Trottein; Nicholas Midzi; Takafira Mduluza; Francisca Mutapi
Journal:  PLoS Negl Trop Dis       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.